{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:41:41Z","timestamp":1790671301594,"version":"4.1.0"},"reference-count":50,"publisher":"Academy of Managed Care Pharmacy","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.18553\/jmcp.2024.24137","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T13:41:25Z","timestamp":1726062085000},"page":"1467-1478","source":"Crossref","is-referenced-by-count":5,"title":["Impact of next-generation sequencing vs polymerase chain reaction testing on payer costs and clinical outcomes throughout the treatment journeys of patients with metastatic non\u2013small cell lung cancer"],"prefix":"10.18553","volume":"30","author":[{"given":"Christine M.","family":"Bestvina","sequence":"first","affiliation":[{"name":"Department of Hematology\/Oncology, University of Chicago Medicine, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexter","family":"Waters","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Morrison","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Montr\u00e9al, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Emond","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Montr\u00e9al, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Lafeuille","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Montr\u00e9al, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalise","family":"Hilts","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Montr\u00e9al, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deo","family":"Mujwara","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Montr\u00e9al, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lefebvre","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc., Montr\u00e9al, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"He","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Vanderpoel","sequence":"additional","affiliation":[{"name":"Janssen Scientific Affairs, LLC, a Johnson & Johnson company, Horsham, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7818","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.4932"},{"key":"R2","unstructured":"American Cancer Society. Key statistics for lung cancer. Accessed November 8, 2023. https:\/\/www.cancer.org\/cancer\/types\/lung-cancer\/about\/key-statistics.html"},{"key":"R3","unstructured":"American Cancer Society. Lung cancer survival rates. Accessed November 8, 2023. https:\/\/www.cancer.org\/cancer\/types\/lung-cancer\/about\/key-statistics.html"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.21037\/pcm.2019.11.03"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2018.01.002"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2021-102"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2019.04.14"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00881-7"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.7293"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2017.11.004"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_237863"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2022.2053403"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2024.2314430"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.3390\/jpm7030005"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4459"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1200\/PO.22.00294"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1200\/PO.18.00356"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2018.1450261"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.e18754"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/j.atg.2016.05.004"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.2217\/pme-2016-0104"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2015.0043"},{"key":"R23","unstructured":"American Cancer Society. Treatment for choices for non-small cell lung cancer, by stage. Accessed May 18, 2023. https:\/\/www.cancer.org\/cancer\/types\/lung-cancer\/treating-non-small-cell\/by-stage.html#treatment-by-stage"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32368"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2015.04.008"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02189-z"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz167"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03414-4"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2018.02.002"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1177\/1049909119878446"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2023-0094"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-3101"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.03.035"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1200\/OP.22.00611"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4411"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.5020"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1200\/PO.22.00246"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.19.00002"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1200\/OP.20.00703"},{"key":"R40","unstructured":"U.S. Food & Drug Administration. FDA grants accelerated approval to sotorasib for KRAS G12C mutated NSCLC. Updated May 28, 2021. Accessed June 29, 2023. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-sotorasib-kras-g12c-mutated-nsclc"},{"key":"R41","unstructured":"U.S. Food & Drug Administration. FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for HER2- mutant non-small cell lung cancer. Updated August 16, 2022. Accessed June 29, 2023. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-her2-mutant-non-small-cell-lung"},{"key":"R42","unstructured":"U.S. Food & Drug Administration. FDA grants accelerated approval to adagrasib for KRAS G12C-mutated NSCLC. Updated December 12, 2022. Accessed June 29, 2023. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-adagrasib-kras-g12c-mutated-nsclc"},{"key":"R43","unstructured":"Rybrevant. Prescribing information. Janssen Biotech, Inc; 2022. Accessed April 29, 2024. https:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/RYBREVANT-pi.pdf"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00662"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2306441"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.10.062"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.10.117"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02709-4"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2024.01.005"},{"key":"R50","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.e13619"}],"container-title":["Journal of Managed Care & Specialty Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T17:39:06Z","timestamp":1732901946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2024.24137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.18553\/jmcp.2024.24137"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2024.24137","relation":{},"ISSN":["2376-0540","2376-1032"],"issn-type":[{"value":"2376-0540","type":"print"},{"value":"2376-1032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}